Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 235

1.

Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).

van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, Withagen AJ, Pasteuning WH, Brouwer J, Lie KI.

J Am Coll Cardiol. 1993 Nov 15;22(6):1564-73.

PMID:
7901256
[PubMed - indexed for MEDLINE]
2.

Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.

van Veldhuisen DJ, Brouwer J, Man in 't Veld AJ, Dunselman PH, Boomsma F, Lie KI.

Am J Cardiol. 1995 Apr 15;75(12):796-800.

PMID:
7717282
[PubMed - indexed for MEDLINE]
3.

Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.

Brouwer J, van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Boomsma F, Haaksma J, Lie KI.

J Am Coll Cardiol. 1995 Oct;26(4):983-90.

PMID:
7560628
[PubMed - indexed for MEDLINE]
Free Article
4.

Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.

Szabó BM, van Veldhuisen DJ, van der Burgh PH, Kruik J, Girbes AR, Lie KI.

J Card Fail. 1996 Sep;2(3):185-92.

PMID:
8891856
[PubMed - indexed for MEDLINE]
5.

Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.

Alicandri C, Fariello R, Boni E, Zaninelli A, Muiesan G.

J Cardiovasc Pharmacol. 1989;14 Suppl 8:S77-82.

PMID:
2483444
[PubMed - indexed for MEDLINE]
6.

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.

Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK.

J Am Coll Cardiol. 1993 Oct;22(4):955-62.

PMID:
8409069
[PubMed - indexed for MEDLINE]
8.

Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.

[No authors listed]

G Ital Cardiol. 1989 Jan;19(1):71-80.

PMID:
2663585
[PubMed - indexed for MEDLINE]
9.

[Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].

Fonseca C, Gouveia R, Ceia F, Mota E, Coelho EM, Gil V, Riva E, Astorga MA, Gomes RS, Luís AS.

Rev Port Cardiol. 1992 Jun;11(6):515-23. Portuguese.

PMID:
1503784
[PubMed - indexed for MEDLINE]
10.

Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor.

Rousseau MF, Konstam MA, Benedict CR, Donckier J, Galanti L, Melin J, Kinan D, Ahn S, Ketelslegers JM, Pouleur H.

Am J Cardiol. 1994 Mar 1;73(7):488-93.

PMID:
7908164
[PubMed - indexed for MEDLINE]
11.
12.

Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.

Cadel A, Brusoni B, Pirelli P, Osculati G, Rovati A, Fanciulli R, Carati L, Valagussa F.

Arzneimittelforschung. 1986 Feb;36(2A):376-9.

PMID:
3707653
[PubMed - indexed for MEDLINE]
13.

Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trial.

Kleber FX, Thyroff-Friesinger U.

Cardiology. 1990;77 Suppl 5:75-80.

PMID:
2279256
[PubMed - indexed for MEDLINE]
14.

Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.

Sher D, Licciardello L, Ferrari V, Sirtori F, Cesana B.

Arzneimittelforschung. 1991 Apr;41(4):402-9.

PMID:
1859514
[PubMed - indexed for MEDLINE]
15.

Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.

Littler WA, Sheridan DJ.

Br Heart J. 1995 May;73(5):428-33.

PMID:
7786657
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group.

Cavalli A, Riva E, Schleman M, Abbondati G, Fuccella LM.

Int J Cardiol. 1989 Mar;22(3):381-7.

PMID:
2707917
[PubMed - indexed for MEDLINE]
17.

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.

Hampton JR, van Veldhuisen DJ, Kleber FX, Cowley AJ, Ardia A, Block P, Cortina A, Cserhalmi L, Follath F, Jensen G, Kayanakis J, Lie KI, Mancia G, Skene AM.

Lancet. 1997 Apr 5;349(9057):971-7.

PMID:
9100622
[PubMed - indexed for MEDLINE]
18.
19.

Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias.

Cocchieri M, Alunni GF, Del Favero A, Fortunati F, Bardelli G, Capponi EA, Regi L, Boschetti E.

Cardiology. 1990;77 Suppl 5:36-42.

PMID:
2126222
[PubMed - indexed for MEDLINE]
20.

Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.

Lieverse AG, van Veldhuisen DJ, Smit AJ, Zijlstra JG, Meijer S, Reitsma WD, Lie KI, Girbes AR.

J Cardiovasc Pharmacol. 1995 Mar;25(3):361-7.

PMID:
7769799
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk